🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Veg Capsule(s) Serving Size
Other Combinations Product Type
33% Evidence Coverage

Supplement Facts — Evidence Check

Calcium
110 mg (11% DV)
IP-6
680 mg
📊 Market median: 260.0mg (249 products) 📚 156 studies (Tier A: 4, B: 61)
This product: 30mg

Other Ingredients

Cellulose Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (89% of products) Nutrient (76% of products)

Target Groups

Vegan Vegetarian Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

SUGGESTED USAGE: As a dietary supplement, take 1 capsule 2 to 3 times daily, preferably on an empty stomach. Consider taking these other NOW(R) products: Ojibwa Herbal Extract, AHCC(R) and EGCg.

⚠️ Warnings & Precautions

Not manufactured with yeast, wheat, gluten, milk, egg, fish, shellfish or tree nut ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Caution: For adults only.

Consult physician if pregnant/nursing, taking medication , or have a medical condition.

Keep out of reach of children.

🧪 Formulation Notes

680 mg - IP-6

Vegetarian/Vegan

Not manufactured with yeast, wheat, gluten, soy, milk, egg, fish, shellfish or tree nut ingredients.

Additional Information

Please Recycle.

CAPSULE SIZE Made in the USA

CODE 0477B V7

HEALTHY CELL GROWTH & REPRODUCTION

~ Proper Calcium Metabolism ~ Fights Oxidized Iron

QUALITY GMP ASSURED

For more product information visit www.nowfoods.com/0477

Store in a cool, dry place after opening.

Inositol Hexaphosphate (IP-6), also known as phytate, is a component of certain dietary fibers found in beans, brown rice, corn, sesame seeds, and other high fiber foods. IP-6 has been found to promote proper calcium cystallization processes in bone, renal, and vascular tissues. IP-6 can inhibit oxidative reactions initiated by iron, one of the major contributors to the proliferation of free radicals in the human body. In addition, IP-6 may support the healthy regulation of cellular growth and reproduction, as well as enhanced activity of NK cells.

Product Details

UPC / SKU 7 33739 00477 2
DSLD Entry Date 2014-05-23
Product Type Other Combinations
Form Capsule
Brand NOW
DSLD ID 33449
Data Updated 2026-04-11

Research Evidence

46 Research Sources
55 Avg Quality Score
23 Meta Analysis
7 Systematic Review
7 Rct
4 Clinical Trial
2 Other
1 Guideline
1 Regulatory Source
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2025
B Phosphate binders for preventing and treating bone disease in chronic kidney disease patients
Meta Analysis The Cochrane database of systematic reviews 2011
B Calcium and phosphorus supplementation of human milk for preterm infants
Systematic Review The Cochrane database of systematic reviews 2017
B Radiographic and clinical outcomes of silicate-substituted calcium phosphate (SiCaP) bone grafts in spinal fusion: Systematic review and meta-analysis
Meta Analysis Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2020
B ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Calcium, phosphorus and magnesium.
Guideline Clinical nutrition (Edinburgh, Scotland) 2018
B Effect of different phosphate binders on fibroblast growth factor 23 levels in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Annals of palliative medicine 2022
B Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia
Meta Analysis The Cochrane database of systematic reviews 2015
B The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of nephrology 2022
B Calcimimetics treatment strategy for serum calcium and phosphate management in patients with secondary hyperparathyroidism undergoing dialysis: A systematic review and meta-analysis of randomized studies
Meta Analysis Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2024
View all evidence for Phosphorus →

Compare Similar Products

View all Phosphorus products →